Chief Executive Officer
Mon, Oct 3, 2022
Oct 3
12,500 shares @ $20.05
Decreased holdings by -1.00%
5th largest trade (out of 185)
Trade made by an officer
57% win rate · -4.5% median edge vs SPY (7 trades, 90-day · small sample)
Price 33% above 200-day moving average
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology